Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Kelch-like protein 42 is a pro-fibrotic ubiquitin E3 ligase involved in in systemic sclerosis.

Lear TB, Lockwood KC, Larsen MB, Tuncer F, Kennerdell JR, Morse C, Valenzi E, Tabib T, Jurczak MJ, Kass DJ, Evankovich JW, Finkel T, Lafyatis R, Liu Y, Chen BB.

J Biol Chem. 2020 Feb 17. pii: jbc.AC119.012066. doi: 10.1074/jbc.AC119.012066. [Epub ahead of print]

2.

The Role of Palliative Care in Reducing Symptoms and Improving Quality of Life for Patients with Idiopathic Pulmonary Fibrosis: A Review.

Zou RH, Kass DJ, Gibson KF, Lindell KO.

Pulm Ther. 2020 Jan 4. doi: 10.1007/s41030-019-00108-2. [Epub ahead of print] Review.

PMID:
32048243
3.

Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival.

Iasella CJ, Winters SA, Kois A, Cho J, Hannan SJ, Koshy R, Moore CA, Ensor CR, Lendermon EA, Morrell MR, Pilewski JM, Sanchez PG, Kass DJ, Alder JK, Nouraie SM, McDyer JF.

Am J Transplant. 2019 Dec 24. doi: 10.1111/ajt.15756. [Epub ahead of print]

PMID:
31874120
4.

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.

Haak AJ, Kostallari E, Sicard D, Ligresti G, Choi KM, Caporarello N, Jones DL, Tan Q, Meridew J, Diaz Espinosa AM, Aravamudhan A, Maiers JL, Britt RD Jr, Roden AC, Pabelick CM, Prakash YS, Nouraie SM, Li X, Zhang Y, Kass DJ, Lagares D, Tager AM, Varelas X, Shah VH, Tschumperlin DJ.

Sci Transl Med. 2019 Oct 30;11(516). pii: eaau6296. doi: 10.1126/scitranslmed.aau6296.

PMID:
31666402
5.

Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients.

Kulkarni T, Yuan K, Tran-Nguyen TK, Kim YI, de Andrade JA, Luckhardt T, Valentine VG, Kass DJ, Duncan SR.

PLoS One. 2019 Oct 4;14(10):e0221905. doi: 10.1371/journal.pone.0221905. eCollection 2019.

6.

Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.

Kass DJ, Nouraie M, Glassberg MK, Ramreddy N, Fernandez K, Harlow L, Zhang Y, Chen J, Kerr GS, Reimold AM, England BR, Mikuls TR, Gibson KF, Dellaripa PF, Rosas IO, Oddis CV, Ascherman DP.

Arthritis Rheumatol. 2019 Sep 18. doi: 10.1002/art.41123. [Epub ahead of print]

PMID:
31532072
7.

Signals and signposts: Biomarkers in IPF and PAH at the crossroads of clinical relevance.

Sullivan DI, Kass DJ.

Respirology. 2019 Nov;24(11):1044-1045. doi: 10.1111/resp.13694. Epub 2019 Sep 5. No abstract available.

8.

GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis.

Zhang Y, Jiang M, Nouraie M, Roth MG, Tabib T, Winters S, Chen X, Sembrat J, Chu Y, Cardenes N, Tuder RM, Herzog EL, Ryu C, Rojas M, Lafyatis R, Gibson KF, McDyer JF, Kass DJ, Alder JK.

Am J Physiol Lung Cell Mol Physiol. 2019 Oct 1;317(4):L510-L521. doi: 10.1152/ajplung.00062.2019. Epub 2019 Aug 21.

9.

Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis.

Morse C, Tabib T, Sembrat J, Buschur KL, Bittar HT, Valenzi E, Jiang Y, Kass DJ, Gibson K, Chen W, Mora A, Benos PV, Rojas M, Lafyatis R.

Eur Respir J. 2019 Aug 22;54(2). pii: 1802441. doi: 10.1183/13993003.02441-2018. Print 2019 Aug.

PMID:
31221805
10.

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.

Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):199-208. doi: 10.1164/rccm.201810-1891OC.

11.

Diagnosis from Afar: Is Remote Multidisciplinary Discussion Appropriate for Interstitial Lung Disease Care?

Valenzi E, Kass DJ.

Ann Am Thorac Soc. 2019 Apr;16(4):434-436. doi: 10.1513/AnnalsATS.201901-035ED. No abstract available.

PMID:
30932702
12.

Treatment of interstitial lung disease: Do the ends justify the means?

Kass DJ.

Respirology. 2019 Jun;24(6):508-509. doi: 10.1111/resp.13526. Epub 2019 Mar 19. No abstract available.

13.

MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.

Bahudhanapati H, Tan J, Dutta JA, Strock SB, Sembrat J, Àlvarez D, Rojas M, Jäger B, Prasse A, Zhang Y, Kass DJ.

J Biol Chem. 2019 Mar 29;294(13):5008-5022. doi: 10.1074/jbc.RA118.004910. Epub 2019 Feb 1.

PMID:
30709904
14.

Assessing Patterns of Palliative Care Referral and Location of Death in Patients with Idiopathic Pulmonary Fibrosis: A Sixteen-Year Single-Center Retrospective Cohort Study.

Zou RH, Nouraie M, Chen X, Saul MI, Kaminski N, Gibson KF, Kass DJ, Lindell KO.

J Palliat Med. 2019 May;22(5):538-544. doi: 10.1089/jpm.2018.0400. Epub 2019 Jan 7.

PMID:
30615545
15.

Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.

Yoon JH, Nouraie M, Chen X, Zou RH, Sellares J, Veraldi KL, Chiarchiaro J, Lindell K, Wilson DO, Kaminski N, Burns T, Trejo Bittar H, Yousem S, Gibson K, Kass DJ.

Respir Res. 2018 Oct 3;19(1):195. doi: 10.1186/s12931-018-0899-4.

16.

A case series describing common radiographic and pathologic patterns of hard metal pneumoconiosis.

Chiarchiaro J, Tomsic LR, Strock S, Veraldi KL, Nouraie M, Sellares J, Lindell KO, Ortiz LA, Sciurba FC, Kucera RF, Yousem SA, Fuhrman CR, Kass DJ, Gibson KF.

Respir Med Case Rep. 2018 Aug 10;25:124-128. doi: 10.1016/j.rmcr.2018.08.006. eCollection 2018.

17.

Clinical Trials in Idiopathic Pulmonary Fibrosis in the "Posttreatment Era".

Gibson KF, Kass DJ.

JAMA. 2018 Jun 12;319(22):2275-2276. doi: 10.1001/jama.2018.6225. No abstract available.

PMID:
29800063
18.

Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.

Li S, Zhao J, Shang D, Kass DJ, Zhao Y.

JCI Insight. 2018 May 17;3(10). pii: 120362. doi: 10.1172/jci.insight.120362. eCollection 2018 May 17. Review.

19.

Inhibition of Raf1 ameliorates bleomycin-induced pulmonary fibrosis through attenuation of TGF-β1 signaling.

Li S, Liu J, Tan J, Li L, Kaltreider MJ, Zhao J, Kass DJ, Shang D, Zhao Y.

Am J Physiol Lung Cell Mol Physiol. 2018 Aug 1;315(2):L241-L247. doi: 10.1152/ajplung.00093.2018. Epub 2018 May 3.

20.

Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations.

Lindell KO, Nouraie M, Klesen MJ, Klein S, Gibson KF, Kass DJ, Rosenzweig MQ.

BMJ Open Respir Res. 2018 Feb 19;5(1):e000272. doi: 10.1136/bmjresp-2017-000272. eCollection 2018.

21.

From bad to worse: when lung cancer complicates idiopathic pulmonary fibrosis.

Strock SB, Alder JK, Kass DJ.

J Pathol. 2018 Apr;244(4):383-385. doi: 10.1002/path.5027. Epub 2018 Feb 14.

22.

Another building in the IPF Manhattan plot skyline.

Alder JK, Kass DJ.

Lancet Respir Med. 2017 Nov;5(11):837-839. doi: 10.1016/S2213-2600(17)30394-6. Epub 2017 Oct 20. No abstract available.

23.

Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.

Kitsios GD, Rojas M, Kass DJ, Fitch A, Sembrat JC, Qin S, Veraldi KL, Gibson KF, Lindell K, Pilewski JM, Methe B, Li K, McDyer J, McVerry BJ, Morris A.

Thorax. 2018 May;73(5):481-484. doi: 10.1136/thoraxjnl-2017-210537. Epub 2017 Aug 11.

24.

Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis.

Li FJ, Surolia R, Li H, Wang Z, Kulkarni T, Liu G, de Andrade JA, Kass DJ, Thannickal VJ, Duncan SR, Antony VB.

J Immunol. 2017 Sep 1;199(5):1596-1605. doi: 10.4049/jimmunol.1700473. Epub 2017 Jul 28.

25.

Unwinding the Collagen Fibrils: Elucidating the Mechanism of Pirfenidone and Nintedanib in Pulmonary Fibrosis.

Bahudhanapati H, Kass DJ.

Am J Respir Cell Mol Biol. 2017 Jul;57(1):10-11. doi: 10.1165/rcmb.2017-0079ED. No abstract available.

26.

Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12.

Tan J, Tedrow JR, Nouraie M, Dutta JA, Miller DT, Li X, Yu S, Chu Y, Juan-Guardela B, Kaminski N, Ramani K, Biswas PS, Zhang Y, Kass DJ.

J Immunol. 2017 Mar 15;198(6):2269-2285. doi: 10.4049/jimmunol.1600610. Epub 2017 Feb 8.

27.

Reply: Promise and Limitations of Relaxin-based Therapies in Chronic Fibrotic Lung Diseases.

Tan J, Kass DJ.

Am J Respir Crit Care Med. 2016 Dec 1;194(11):1435-1436. No abstract available.

28.

De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II.

Jacko AM, Nan L, Li S, Tan J, Zhao J, Kass DJ, Zhao Y.

Cell Death Dis. 2016 Nov 17;7(11):e2474. doi: 10.1038/cddis.2016.371.

29.

Time to share: lessons from post hoc analyses of IPF trials.

Kass DJ, Kaminski N.

Thorax. 2017 Feb;72(2):101-102. doi: 10.1136/thoraxjnl-2016-209293. Epub 2016 Oct 27. No abstract available.

30.

Referral to Palliative Care Infrequent in Patients with Idiopathic Pulmonary Fibrosis Admitted to an Intensive Care Unit.

Liang Z, Hoffman LA, Nouraie M, Kass DJ, Donahoe MP, Gibson KF, Saul MI, Lindell KO.

J Palliat Med. 2017 Feb;20(2):134-140. doi: 10.1089/jpm.2016.0258. Epub 2016 Oct 18.

PMID:
27754815
31.

Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis.

Nan L, Jacko AM, Tan J, Wang D, Zhao J, Kass DJ, Ma H, Zhao Y.

Sci Rep. 2016 Sep 8;6:33116. doi: 10.1038/srep33116.

32.

miR-155 in the progression of lung fibrosis in systemic sclerosis.

Christmann RB, Wooten A, Sampaio-Barros P, Borges CL, Carvalho CR, Kairalla RA, Feghali-Bostwick C, Ziemek J, Mei Y, Goummih S, Tan J, Alvarez D, Kass DJ, Rojas M, de Mattos TL, Parra E, Stifano G, Capelozzi VL, Simms RW, Lafyatis R.

Arthritis Res Ther. 2016 Jul 5;18(1):155. doi: 10.1186/s13075-016-1054-6.

33.

Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.

Tan J, Tedrow JR, Dutta JA, Juan-Guardela B, Nouraie M, Chu Y, Trejo Bittar H, Ramani K, Biswas PS, Veraldi KL, Kaminski N, Zhang Y, Kass DJ.

Am J Respir Crit Care Med. 2016 Dec 1;194(11):1392-1402.

34.

Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4.

Lear T, McKelvey AC, Rajbhandari S, Dunn SR, Coon TA, Connelly W, Zhao JY, Kass DJ, Zhang Y, Liu Y, Chen BB.

J Exp Med. 2016 May 30;213(6):1029-46. doi: 10.1084/jem.20151229. Epub 2016 May 9.

35.

Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, Joynt KE, Kass DJ, Stephens T, Stanislawski MA, Swenson ER, Goldstein RH, Leopold JA, Zamanian RT, Elwing JM, Plomondon ME, Grunwald GK, Barón AE, Rumsfeld JS, Choudhary G.

Circulation. 2016 Mar 29;133(13):1240-8. doi: 10.1161/CIRCULATIONAHA.115.020207. Epub 2016 Feb 12.

36.

VCAM-1 is a TGF-β1 inducible gene upregulated in idiopathic pulmonary fibrosis.

Agassandian M, Tedrow JR, Sembrat J, Kass DJ, Zhang Y, Goncharova EA, Kaminski N, Mallampalli RK, Vuga LJ.

Cell Signal. 2015 Dec;27(12):2467-73. doi: 10.1016/j.cellsig.2015.09.003. Epub 2015 Sep 18.

37.

Micromanaging microRNAs: using murine models to study microRNAs in lung fibrosis.

Lino Cardenas CL, Kaminski N, Kass DJ.

Drug Discov Today Dis Models. 2013 Fall;10(3):e145-e151.

38.

Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.

Yu G, Herazo-Maya JD, Nukui T, Romkes M, Parwani A, Juan-Guardela BM, Robertson J, Gauldie J, Siegfried JM, Kaminski N, Kass DJ.

Am J Respir Crit Care Med. 2014 Oct 1;190(7):780-90. doi: 10.1164/rccm.201310-1903OC.

39.

Autoreactivity to glucose regulated protein 78 links emphysema and osteoporosis in smokers.

Bon J, Kahloon R, Zhang Y, Xue J, Fuhrman CR, Tan J, Burger M, Kass DJ, Csizmadia E, Otterbein L, Chandra D, Bhargava A, Pilewski JM, Roodman GD, Sciurba FC, Duncan SR.

PLoS One. 2014 Sep 12;9(9):e105066. doi: 10.1371/journal.pone.0105066. eCollection 2014.

40.

C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.

Vuga LJ, Tedrow JR, Pandit KV, Tan J, Kass DJ, Xue J, Chandra D, Leader JK, Gibson KF, Kaminski N, Sciurba FC, Duncan SR.

Am J Respir Crit Care Med. 2014 Apr 15;189(8):966-74. doi: 10.1164/rccm.201309-1592OC.

41.

Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients.

Xue J, Kass DJ, Bon J, Vuga L, Tan J, Csizmadia E, Otterbein L, Soejima M, Levesque MC, Gibson KF, Kaminski N, Pilewski JM, Donahoe M, Sciurba FC, Duncan SR.

J Immunol. 2013 Sep 1;191(5):2089-95. doi: 10.4049/jimmunol.1203476. Epub 2013 Jul 19.

42.

Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.

Kahloon RA, Xue J, Bhargava A, Csizmadia E, Otterbein L, Kass DJ, Bon J, Soejima M, Levesque MC, Lindell KO, Gibson KF, Kaminski N, Banga G, Oddis CV, Pilewski JM, Sciurba FC, Donahoe M, Zhang Y, Duncan SR.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):768-75. doi: 10.1164/rccm.201203-0506OC.

43.

Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats.

Kass DJ, Rattigan E, Kahloon R, Loh K, Yu L, Savir A, Markowski M, Saqi A, Rajkumar R, Ahmad F, Champion HC.

PLoS One. 2012;7(4):e35388. doi: 10.1371/journal.pone.0035388. Epub 2012 Apr 11.

44.

Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.

Kass DJ, Yu G, Loh KS, Savir A, Borczuk A, Kahloon R, Juan-Guardela B, Deiuliis G, Tedrow J, Choi J, Richards T, Kaminski N, Greenberg SM.

Am J Pathol. 2012 May;180(5):1963-78. doi: 10.1016/j.ajpath.2012.01.010. Epub 2012 Mar 16.

45.

Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes.

Kass DJ, Kaminski N.

Clin Transl Sci. 2011 Oct;4(5):372-9. doi: 10.1111/j.1752-8062.2011.00287.x. Review.

46.

Cytokine-like factor 1 (CLF1): life after development?

Kass DJ.

Cytokine. 2011 Sep;55(3):325-9. doi: 10.1016/j.cyto.2011.05.021. Epub 2011 Jun 28. Review.

47.

Thioridazine improves affective symptoms in schizophrenic patients.

Dufresne RL, Valentino D, Kass DJ.

Psychopharmacol Bull. 1993;29(2):249-55.

PMID:
8290673
48.

Behavioral group treatment of hysteria.

Kass DJ, Silvers FM, Abroms GM.

Arch Gen Psychiatry. 1972 Jan;26(1):42-50. No abstract available.

PMID:
5009426
49.

The biosynthesis of salicyl glucuronides by tissue slices of various organs.

SCHACHTER D, KASS DJ, LANNON TJ.

J Biol Chem. 1959 Jan;234(1):201-5. No abstract available.

Supplemental Content

Support Center